TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 ,inter alia, to consider and approve 1) To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2023.
2) To consider and approve the closure of subsidiary company M/s. Peroral Bio Private Limited.
3) To consider and approve an extension for the date of Annual General Meeting (AGM) of the Company for the financial year 2022-23.
4) To consider and approve the appointment of M/s Geeta Serwani & Associates, as Secretarial Auditor of the Company for the financial year 2022-23.
5) To consider and approve the appointment of Ms. Vasavi & Co, as Internal Auditors of the Company for the financial year 2022-23.
6) To transact such other business as may be required.
|